Partnership to support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.
New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide
Study run in partnership with the CANTAM network and published in PLoS Medicine supports further uptake of antimalarial in Africa.
Pyronaridine-artesunate demonstrates high real-life safety, tolerability and effectiveness in the treatment of uncomplicated malaria in large multi-country study in Africa
Trends in Parasitology publishes MMV’s new strategy to assess risk of resistance early in preclinical development.